BMRN SEC filings (2026)
CIK 1048477 · Pharmaceutical Preparations (SIC 2834) · incorporated in DE · fiscal year ends in December
2,723 filings on EDGAR since 1999 · 33 annual, 85 quarterly, 368 current · financial statements · earnings
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by what they covered, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
- Sep 308-K8-K · Material definitive agreement
- Sep 158-K8-K · Other events
- Sep 148-K8-K · Directors or officers; compensation
- Sep 2Insider saleDavis George Eric (EVP, Chief Legal Officer) sold 17,557 shares for $1.2M at $66.28
- Sep 18-K8-K · Other events
August 2026
- Aug 318-K8-K · Material definitive agreement; Regulation FD disclosure
- Aug 188-K8-K · Material definitive agreement; Regulation FD disclosure
- Aug 6EarningsEarnings release — EPS $0.90 vs $0.79 est. (+13.9%); revenue $989.7M (+20% y/y) 3.8%
- Aug 6ReportQuarterly report, Q2 2026 — revenue $989.7M (+20% y/y), net income $44.8M, EPS $0.23
July 2026
- Jul 138-K8-K · Other events
June 2026
May 2026
April 2026
- Apr 278-K8-K · Material definitive agreement; Completion of an acquisition or disposition; New financial obligation; Regulation FD disclosure
- Apr 238-K8-K · Other events
- Apr 21ProxyProxy · Annual report to shareholders
- Apr 21ProxyProxy · Additional proxy materials
- Apr 21ProxyProxy · Proxy statement
March 2026
- Mar 168-K8-K · Other events
- Mar 11Insider saleGuyer Charles Greg (EVP, Chief Technical Officer) sold 16,486 shares for $997K at $60.46
February 2026
- Feb 26ReportAnnual report, FY2025 — revenue $3.22B (+13% y/y), net income $348.9M, EPS $1.80
- Feb 26Insider saleDavis George Eric (EVP, Chief Legal Officer) sold 26,061 shares for $1.6M at $61.36
- Feb 26Insider saleFriberg Gregory R (EVP, Chief R&D Officer) sold 6,326 shares for $382K at $60.38
- Feb 23EarningsEarnings release — EPS $0.28 vs $0.07 est. (+300.0%); revenue $874.6M (+17% y/y) 0.5%
- Feb 128-K8-K · Material definitive agreement; New financial obligation; Regulation FD disclosure
January 2026
- Jan 298-K8-K · Regulation FD disclosure
- Jan 268-K8-K · Results of operations; Regulation FD disclosure; Other events
- Jan 128-K8-K · Results of operations
December 2025
- Dec 228-K8-K · Other events
- Dec 198-K8-K · Material definitive agreement; Regulation FD disclosure
- Dec 178-K8-K · Directors or officers; compensation
October 2025
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $4.3M in 5 sales and bought nothing on the open market; 46 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Sep 2, 2026Form 4 | Davis George EricEVP, Chief Legal OfficerSold · $1.2M · 17,557 sh |
| May 7, 2026Form 4 | Friberg Gregory REVP, Chief R&D OfficerSold · $177K · 3,281 sh |
| Mar 11, 2026Form 4 | Guyer Charles GregEVP, Chief Technical OfficerSold · $997K · 16,486 sh |
| Feb 26, 2026Form 4 | Davis George EricEVP, Chief Legal OfficerSold · $1.6M · 26,061 sh |
| Feb 26, 2026Form 4 | Friberg Gregory REVP, Chief R&D OfficerSold · $382K · 6,326 sh |
Awards, exercises, withholding and plan purchases · 46 transactions
| Date | Insider |
|---|---|
| Sep 30, 2026Form 4 | Friberg Gregory REVP, Chief R&D OfficerTax withholding · $245K · 4,086 sh |
| Sep 10, 2026Form 4 | Plenge Robert MDirectorAward · $0 · 6,140 sh |
| Jun 2, 2026Form 4 | ANDERSON ELIZABETH MDirectorAward · $0 · 7,490 sh |
| Jun 2, 2026Form 4 | Bodem Barbara W.DirectorAward · $0 · 7,490 sh |
| Jun 2, 2026Form 4 | CLARK IAN TDirectorAward · $0 · 7,490 sh |
| Jun 2, 2026Form 4 | Dere Willard HDirectorAward · $0 · 7,490 sh |
| Jun 2, 2026Form 4 | Enyedy Mark JDirectorAward · $0 · 7,490 sh |
| Jun 2, 2026Form 4 | HOMBACH ROBERT J.DirectorAward · $0 · 7,490 sh |
| Jun 2, 2026Form 4 | Ho MaykinDirectorAward · $0 · 7,490 sh |
| Jun 2, 2026Form 4 | Walbert Timothy PDirectorAward · $0 · 7,490 sh |
| Jun 2, 2026Form 4 | Countouriotis AthenaDirectorAward · $0 · 7,490 sh |
| May 20, 2026Form 4 | Hubbard CristinEVP, Chief Commercial OfficerTax withholding · $116K · 2,318 sh |
| Mar 18, 2026Form 4 | Davis George EricEVP, Chief Legal OfficerTax withholding · $71K · 1,273 sh |
| Mar 17, 2026Form 4 | Hardy AlexanderChief Executive Officer · DirectorTax withholding · $238K · 4,252 sh |
| Mar 17, 2026Form 4 | Mueller BrianEVP, Chief Financial OfficerTax withholding · $119K · 2,117 sh |
| Mar 17, 2026Form 4 | Guyer Charles GregEVP, Chief Technical OfficerTax withholding · $95K · 1,693 sh |
| Mar 17, 2026Form 4 | Friberg Gregory REVP, Chief R&D OfficerTax withholding · $91K · 1,629 sh |
| Mar 17, 2026Form 4 | Hubbard CristinEVP, Chief Commercial OfficerTax withholding · $70K · 1,245 sh |
| Mar 16, 2026Form 4 | Davis George EricEVP, Chief Legal OfficerTax withholding · $420K · 7,177 sh |
| Mar 16, 2026Form 4 | Hardy AlexanderChief Executive Officer · DirectorAward · Stock Option (Right to Buy… · $0 · 89,200 sh |
| Mar 16, 2026Form 4 | Hardy AlexanderChief Executive Officer · DirectorAward · $0 · 62,440 sh |
| Mar 16, 2026Form 4 | Friberg Gregory REVP, Chief R&D OfficerAward · Stock Option (Right to Buy… · $0 · 45,600 sh |
| Mar 16, 2026Form 4 | Mueller BrianEVP, Chief Financial OfficerAward · Stock Option (Right to Buy… · $0 · 44,600 sh |
| Mar 16, 2026Form 4 | Hubbard CristinEVP, Chief Commercial OfficerAward · Stock Option (Right to Buy… · $0 · 36,680 sh |
| Mar 16, 2026Form 4 | Guyer Charles GregEVP, Chief Technical OfficerAward · Stock Option (Right to Buy… · $0 · 35,680 sh |
| Mar 16, 2026Form 4 | Davis George EricEVP, Chief Legal OfficerAward · Stock Option (Right to Buy… · $0 · 34,690 sh |
| Mar 16, 2026Form 4 | Friberg Gregory REVP, Chief R&D OfficerAward · $0 · 19,150 sh |
| Mar 16, 2026Form 4 | Mueller BrianEVP, Chief Financial OfficerAward · $0 · 18,740 sh |
| Mar 16, 2026Form 4 | Hubbard CristinEVP, Chief Commercial OfficerAward · $0 · 15,410 sh |
| Mar 16, 2026Form 4 | Guyer Charles GregEVP, Chief Technical OfficerAward · $0 · 14,990 sh |
| Mar 16, 2026Form 4 | Davis George EricEVP, Chief Legal OfficerAward · $0 · 14,570 sh |
| Mar 13, 2026Form 4 | Mueller BrianEVP, Chief Financial OfficerTax withholding · $582K · 9,945 sh |
| Mar 13, 2026Form 4 | Guyer Charles GregEVP, Chief Technical OfficerTax withholding · $533K · 9,109 sh |
| Mar 13, 2026Form 4 | Hardy AlexanderChief Executive Officer · DirectorTax withholding · $172K · 2,941 sh |
| Feb 25, 2026Form 4 | Mueller BrianEVP, Chief Financial OfficerAward · $0 · 16,482 sh |
| Feb 25, 2026Form 4 | Davis George EricEVP, Chief Legal OfficerAward · $0 · 15,224 sh |
| Feb 25, 2026Form 4 | Guyer Charles GregEVP, Chief Technical OfficerAward · $0 · 15,222 sh |
| Jan 20, 2026Form 4 | Ramchandani Rashmi VirendraVP, Chief Accounting OfficerAward · $0 · 25,610 sh |
| Jan 20, 2026Form 4 | Ramchandani Rashmi VirendraVP, Chief Accounting OfficerAward · Stock Option (Right to Buy… · $0 · 18,220 sh |
| Dec 30, 2025Form 4 | MEIER RICHARD ADirectorGift · $0 · 500 sh |
| Oct 31, 2025Form 4 | Friberg Gregory REVP, Chief R&D OfficerAward · $18K · 398 sh |
| Oct 31, 2025Form 4 | Hubbard CristinEVP, Chief Commercial OfficerAward · $3,643 · 80 sh |
| Oct 31, 2025Form 4 | Guyer Charles GregEVP, Chief Technical OfficerAward · $2,823 · 62 sh |
| Apr 30, 2025Form 4 | Davis George EricEVP, Chief Legal OfficerAward · $20K · 375 sh |
| Apr 30, 2025Form 4 | Mueller BrianEVP, Chief Financial OfficerAward · $20K · 375 sh |
| Apr 30, 2025Form 4 | Guyer Charles GregEVP, Chief Technical OfficerAward · $17K · 317 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K is described by its items. A form opens the document on EDGAR, or the filing’s index where it furnishes exhibits (an earnings release is the 8-K’s Exhibit 99.1).
2026 · 24 filings
| Filed | What it is |
|---|---|
| Sep 30, 20268-K | Material definitive agreement |
| Sep 15, 20268-K | Other events |
| Sep 14, 20268-K | Directors or officers; compensation |
| Sep 1, 20268-K | Other events |
| Aug 31, 20268-K | Material definitive agreement; Regulation FD disclosure |
| Aug 18, 20268-K | Material definitive agreement; Regulation FD disclosure |
| Aug 6, 202610-Q | Quarterly report, Q2 2026 — revenue $989.7M (+20% y/y), net income $44.8M, EPS $0.23 |
| Aug 6, 20268-K | Earnings release — EPS $0.90 vs $0.79 est. (+13.9%); revenue $989.7M (+20% y/y) 3.8% |
| Jul 13, 20268-K/A | Other events |
| Jun 4, 20268-K | Directors or officers; compensation; Shareholder vote results |
| May 5, 202610-Q | Quarterly report, Q1 2026 — revenue $766.2M (+3% y/y), net income $105.5M, EPS $0.54 |
| May 4, 20268-K | Earnings release — EPS $0.58 vs $0.78 est. (−25.6%); revenue $766.2M (+3% y/y) 4.0% |
| Apr 27, 20268-K | Material definitive agreement; Completion of an acquisition or disposition; New financial obligation; Regulation FD disclosure |
| Apr 23, 20268-K | Other events |
| Apr 21, 2026ARS | Annual report to shareholders |
| Apr 21, 2026DEFA14A | Additional proxy materials |
| Apr 21, 2026DEF 14A | Proxy statement |
| Mar 16, 20268-K | Other events |
| Feb 26, 202610-K | Annual report, FY2025 — revenue $3.22B (+13% y/y), net income $348.9M, EPS $1.80 |
| Feb 23, 20268-K | Earnings release — EPS $0.28 vs $0.07 est. (+300.0%); revenue $874.6M (+17% y/y) 0.5% |
| Feb 12, 20268-K | Material definitive agreement; New financial obligation; Regulation FD disclosure |
| Jan 29, 20268-K | Regulation FD disclosure |
| Jan 26, 20268-K | Results of operations; Regulation FD disclosure; Other events |
| Jan 12, 20268-K | Results of operations |
2025 · 21 filings
| Filed | What it is |
|---|---|
| Dec 22, 20258-K | Other events |
| Dec 19, 20258-K | Material definitive agreement; Regulation FD disclosure |
| Dec 17, 20258-K | Directors or officers; compensation |
| Oct 28, 202510-Q | Quarterly report, Q3 2025 — revenue $776.1M (+4% y/y), net income −$30.7M, EPS −$0.16 |
| Oct 27, 20258-K | Earnings release — EPS −$0.08 vs $0.82 est. (−109.8%); revenue $776.1M (+4% y/y) 1.6% |
| Oct 7, 20258-K | Results of operations |
| Aug 11, 20258-K | Directors or officers; compensation |
| Aug 5, 202510-Q | Quarterly report, Q2 2025 — revenue $825.4M (+16% y/y), net income $240.5M, EPS $1.23 |
| Aug 4, 20258-K | Results of operations |
| Aug 1, 20258-K | Directors or officers; compensation |
| May 22, 20258-K | Directors or officers; compensation; Shareholder vote results |
| May 16, 20258-K | Material definitive agreement; Regulation FD disclosure |
| May 2, 202510-Q | Quarterly report, Q1 2025 — revenue $745.1M (+15% y/y), net income $185.7M, EPS $0.95 |
| May 1, 20258-K | Results of operations |
| Apr 8, 2025ARS | Annual report to shareholders |
| Apr 8, 2025DEFA14A | Additional proxy materials |
| Apr 8, 2025DEF 14A | Proxy statement |
| Mar 3, 20258-K | Change to security holders' rights; Charter, bylaws or fiscal-year change |
| Feb 24, 20258-K | Directors or officers; compensation |
| Feb 24, 202510-K | Annual report, FY2024 — revenue $2.85B (+18% y/y), net income $426.9M, EPS $2.21 |
| Feb 19, 20258-K | Results of operations |
2024 · 19 filings
| Filed | What it is |
|---|---|
| Oct 31, 202410-Q | Quarterly report, Q3 2024 — revenue $745.7M (+28% y/y), net income $106.1M, EPS $0.55 |
| Oct 29, 20248-K | Results of operations |
| Sep 24, 20248-K | Regulation FD disclosure |
| Sep 4, 20248-K | Material definitive agreement; New financial obligation |
| Aug 28, 20248-K | Exit or disposal costs |
| Aug 22, 20248-K | Directors or officers; compensation |
| Aug 5, 202410-Q | Quarterly report, Q2 2024 — revenue $712.0M (+20% y/y), net income $107.2M, EPS $0.55 |
| Aug 5, 20248-K | Results of operations |
| May 24, 20248-K | Shareholder vote results |
| May 14, 20248-K | Exit or disposal costs |
| Apr 26, 202410-Q | Quarterly report, Q1 2024 — revenue $648.8M (+9% y/y), net income $88.7M, EPS $0.46 |
| Apr 24, 20248-K | Results of operations |
| Apr 23, 20248-K | Other events |
| Apr 9, 2024ARS | Annual report to shareholders |
| Apr 9, 2024DEFA14A | Additional proxy materials |
| Apr 9, 2024DEF 14A | Proxy statement |
| Feb 26, 202410-K | Annual report, FY2023 — revenue $2.42B (+15% y/y), net income $167.6M, EPS $0.87 |
| Feb 22, 20248-K | Results of operations |
| Jan 11, 20248-K | Directors or officers; compensation |
2023 · 15 filings — 8 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Nov 2, 202310-Q | Quarterly report, Q3 2023 — revenue $581.3M (+15% y/y), net income $40.4M, EPS $0.21 |
| Aug 2, 202310-Q | Quarterly report, Q2 2023 — revenue $595.3M (+12% y/y), net income $56.0M, EPS $0.29 |
| Apr 28, 202310-Q | Quarterly report, Q1 2023 — revenue $596.4M (+15% y/y), net income $50.9M, EPS $0.27 |
| Apr 11, 2023ARS | Annual report to shareholders |
| Apr 11, 2023DEFA14A | Additional proxy materials |
| Apr 11, 2023DEF 14A | Proxy statement |
| Feb 27, 202310-K | Annual report, FY2022 — revenue $2.10B (+14% y/y), net income $141.6M, EPS $0.75 |
8 current reports (8-K) not listed; the year is on EDGAR.
2022 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Oct 28, 202210-Q | Quarterly report, Q3 2022 — revenue $505.3M (+24% y/y), net income −$6.7M, EPS −$0.04 |
| Aug 4, 202210-Q | Quarterly report, Q2 2022 — revenue $533.8M (+6% y/y), net income $27.7M, EPS $0.15 |
| Apr 29, 202210-Q | Quarterly report, Q1 2022 — revenue $519.4M (+7% y/y), net income $120.8M, EPS $0.63 |
| Apr 12, 2022DEFA14A | Additional proxy materials |
| Apr 12, 2022DEF 14A | Proxy statement |
| Feb 25, 202210-K | Annual report, FY2021 — revenue $1.85B (−1% y/y), net income −$64.1M, EPS −$0.35 |
10 current reports (8-K) not listed; the year is on EDGAR.
2021 · 16 filings — 9 × 8-K, 3 × 10-Q, 2 × DEFA14A and 2 other forms
| Filed | What it is |
|---|---|
| Oct 29, 202110-Q | Quarterly report, Q3 2021 — revenue $408.7M (−14% y/y), net income −$36.5M, EPS −$0.20 |
| Jul 30, 202110-Q | Quarterly report, Q2 2021 — revenue $501.7M (+17% y/y), net income $12.9M, EPS $0.07 |
| May 17, 2021DEFA14A | Additional proxy materials |
| Apr 30, 202110-Q | Quarterly report, Q1 2021 — revenue $486.0M (−3% y/y), net income $17.4M, EPS $0.09 |
| Apr 13, 2021DEFA14A | Additional proxy materials |
| Apr 13, 2021DEF 14A | Proxy statement |
| Feb 26, 202110-K | Annual report, FY2020 — revenue $1.86B (+9% y/y), net income $854.0M, EPS $4.50 |
9 current reports (8-K) not listed; the year is on EDGAR.
2020 · 18 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Nov 6, 202010-Q | Quarterly report, Q3 2020 — revenue $476.8M (+3% y/y), net income $784.8M, EPS $4.01 |
| Aug 5, 202010-Q | Quarterly report, Q2 2020 — revenue $429.5M (+11% y/y), net income −$29.2M, EPS −$0.16 |
| May 1, 202010-Q | Quarterly report, Q1 2020 — revenue $502.1M (+25% y/y), net income $81.4M, EPS $0.44 |
| Apr 14, 2020DEFA14A | Additional proxy materials |
| Apr 14, 2020DEF 14A | Proxy statement |
| Feb 27, 202010-K | Annual report, FY2019 — revenue $1.70B (+14% y/y), net income −$23.8M, EPS −$0.13 |
12 current reports (8-K) not listed; the year is on EDGAR.
2019 · 14 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
| Filed | What it is |
|---|---|
| Nov 4, 201910-Q/A | Quarterly report, amended |
| Oct 29, 201910-Q | Quarterly report |
| Aug 2, 201910-Q | Quarterly report, Q2 2019 — revenue $387.8M (+4% y/y), net income −$37.4M, EPS −$0.21 |
| Apr 29, 201910-Q | Quarterly report, Q1 2019 — revenue $400.7M (+7% y/y), net income −$56.5M, EPS −$0.32 |
| Apr 23, 2019DEFA14A | Additional proxy materials |
| Apr 23, 2019DEF 14A | Proxy statement |
| Feb 28, 201910-K | Annual report, FY2018 — revenue $1.49B (+14% y/y), net income −$77.2M, EPS −$0.44 |
7 current reports (8-K) not listed; the year is on EDGAR.
2018 · 13 filings — 7 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
| Filed | What it is |
|---|---|
| Oct 26, 201810-Q | Quarterly report, Q3 2018 — revenue $391.7M (+17% y/y), net income −$12.6M, EPS −$0.07 |
| Aug 3, 201810-Q | Quarterly report, Q2 2018 — revenue $372.8M (+17% y/y), net income −$16.8M |
| Apr 27, 201810-Q | Quarterly report, Q1 2018 — revenue $373.4M (+23% y/y), net income −$44.1M, EPS −$0.26 |
| Apr 24, 2018DEFA14A | Additional proxy materials |
| Apr 24, 2018DEF 14A | Proxy statement |
| Feb 26, 201810-K | Annual report, FY2017 — revenue $1.31B (+18% y/y), net income −$117.0M, EPS −$0.67 |
7 current reports (8-K) not listed; the year is on EDGAR.
2017 · 17 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
| Filed | What it is |
|---|---|
| Nov 13, 201710-Q/A | Quarterly report, amended |
| Oct 31, 201710-Q | Quarterly report, Q3 2017 — revenue $334.1M (+19% y/y), net income −$12.5M, EPS −$0.07 |
| Aug 2, 201710-Q | Quarterly report, Q2 2017 — revenue $317.4M (+6% y/y), net income −$36.8M |
| May 4, 201710-Q | Quarterly report, Q1 2017 — revenue $303.7M (+28% y/y), net income −$16.3M, EPS −$0.09 |
| Apr 25, 2017DEFA14A | Additional proxy materials |
| Apr 25, 2017DEF 14A | Proxy statement |
| Apr 11, 2017PRE 14A | Preliminary proxy statement |
| Feb 27, 201710-K | Annual report, FY2016 — revenue $1.12B (+26% y/y), net income −$630.2M, EPS −$3.81 |
9 current reports (8-K) not listed; the year is on EDGAR.
2016 · 21 filings — 13 × 8-K, 3 × 10-Q, 2 × 8-K/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2015 · 25 filings — 17 × 8-K, 3 × 10-Q, 1 × 10-K and 4 other forms
Counted, not listed; the year is on EDGAR.
2014 · 24 filings — 15 × 8-K, 3 × 10-Q, 2 × 8-K/A and 4 other forms
Counted, not listed; the year is on EDGAR.
2013 · 22 filings — 15 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2012 · 20 filings — 13 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2011 · 16 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2010 · 23 filings — 13 × 8-K, 3 × 10-Q, 2 × 8-K/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2009 · 19 filings — 12 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2008 · 14 filings — 9 × 8-K, 3 × 10-Q, 1 × 10-K and 1 other form
Counted, not listed; the year is on EDGAR.
2007 · 17 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 3 other forms
Counted, not listed; the year is on EDGAR.
2006 · 23 filings — 17 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2005 · 42 filings — 22 × 8-K, 3 × 10-Q, 2 × 10-K/A and 9 other forms
Counted, not listed; the year is on EDGAR.
2004 · 29 filings — 21 × 8-K, 3 × 10-Q, 2 × 8-K/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2003 · 31 filings — 23 × 8-K, 3 × 10-Q, 2 × 8-K/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2002 · 39 filings — 25 × 8-K, 3 × 10-Q, 3 × 8-K/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2001 · 16 filings — 10 × 8-K, 3 × 10-Q, 1 × 10-K and 2 other forms
Counted, not listed; the year is on EDGAR.
2000 · 6 filings — 3 × 10-Q, 1 × 10-K, 1 × 8-K and 1 other form
Counted, not listed; the year is on EDGAR.
1999 · 2 filings — 2 × 10-Q
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 46 filings — 30 × 4, 6 × 5, 5 × 144 and 4 other forms
| Filed | What it is |
|---|---|
| Oct 1, 20264 | Insider transaction (Form 4) |
| Sep 14, 20264 | Insider transaction (Form 4) |
| Sep 14, 20263 | Initial insider holdings (Form 3) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Sep 2, 2026144 | Notice of proposed sale (Form 144) |
| Aug 6, 2026S-8 | Employee stock plan registration |
| Jun 4, 20264 | Insider transaction (Form 4) |
| Jun 4, 20264 | Insider transaction (Form 4) |
| Jun 4, 20264 | Insider transaction (Form 4) |
| Jun 4, 20264 | Insider transaction (Form 4) |
| Jun 4, 20264 | Insider transaction (Form 4) |
| Jun 4, 20264 | Insider transaction (Form 4) |
| Jun 4, 20264 | Insider transaction (Form 4) |
| Jun 4, 20264 | Insider transaction (Form 4) |
| Jun 4, 20264 | Insider transaction (Form 4) |
| May 21, 20264 | Insider transaction (Form 4) |
| May 11, 20264 | Insider transaction (Form 4) |
| May 7, 2026144 | Notice of proposed sale (Form 144) |
| Apr 29, 2026SCHEDULE 13G | Other filings |
| Mar 26, 2026SCHEDULE 13G/A | Other filings |
| Mar 19, 20264 | Insider transaction (Form 4) |
| Mar 19, 20264 | Insider transaction (Form 4) |
| Mar 19, 20264 | Insider transaction (Form 4) |
| Mar 19, 20264 | Insider transaction (Form 4) |
| Mar 18, 20264 | Insider transaction (Form 4) |
The newest 25 of 46 shown; the full year is on EDGAR.
2025 · 55 filings — 30 × 4, 6 × SCHEDULE 13G/A, 5 × 144 and 7 other forms
| Filed | What it is |
|---|---|
| Dec 2, 20254 | Insider transaction (Form 4) |
| Nov 14, 2025SCHEDULE 13G/A | Other filings |
| Oct 2, 20254 | Insider transaction (Form 4) |
| Aug 14, 2025SCHEDULE 13G/A | Other filings |
| Aug 14, 2025SCHEDULE 13G/A | Other filings |
| Aug 5, 20254 | Insider transaction (Form 4) |
| Aug 5, 20253 | Initial insider holdings (Form 3) |
| Aug 5, 2025S-8 | Employee stock plan registration |
| Jul 1, 2025SC TO-T/A | Beneficial ownership |
| Jun 17, 2025SC TO-T/A | Beneficial ownership |
| Jun 13, 2025CORRESP | Letter to the SEC |
| Jun 13, 2025SC TO-T/A | Beneficial ownership |
| Jun 4, 2025SC TO-T/A | Beneficial ownership |
| Jun 2, 2025SC TO-T | Beneficial ownership |
| May 22, 20254 | Insider transaction (Form 4) |
| May 22, 20254 | Insider transaction (Form 4) |
| May 22, 20254 | Insider transaction (Form 4) |
| May 22, 20254 | Insider transaction (Form 4) |
| May 22, 20254 | Insider transaction (Form 4) |
| May 22, 20254 | Insider transaction (Form 4) |
| May 22, 20254 | Insider transaction (Form 4) |
| May 22, 20254 | Insider transaction (Form 4) |
| May 22, 20254 | Insider transaction (Form 4) |
| May 22, 20254 | Insider transaction (Form 4) |
| May 20, 20254 | Insider transaction (Form 4) |
The newest 25 of 55 shown; the full year is on EDGAR.
2024 · 91 filings — 51 × 4, 26 × 144, 5 × SC 13G/A and 5 other forms
| Filed | What it is |
|---|---|
| Dec 3, 20244 | Insider transaction (Form 4) |
| Nov 14, 20244 | Insider transaction (Form 4) |
| Nov 12, 2024144 | Notice of proposed sale (Form 144) |
| Oct 3, 2024UPLOAD | Letter from the SEC staff |
| Oct 1, 20244 | Insider transaction (Form 4) |
| Oct 1, 20243 | Initial insider holdings (Form 3) |
| Sep 30, 2024SC 13G | Passive holder above 5% (Schedule 13G) |
| Sep 17, 20244 | Insider transaction (Form 4) |
| Sep 16, 2024CORRESP | Letter to the SEC |
| Sep 2, 2024UPLOAD | Letter from the SEC staff |
| Aug 15, 20244 | Insider transaction (Form 4) |
| Aug 13, 2024144 | Notice of proposed sale (Form 144) |
| Jul 10, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Jul 1, 20244 | Insider transaction (Form 4) |
| Jun 4, 20244 | Insider transaction (Form 4) |
| Jun 4, 20244 | Insider transaction (Form 4) |
| Jun 4, 2024144 | Notice of proposed sale (Form 144) |
| May 31, 20244 | Insider transaction (Form 4) |
| May 31, 2024144 | Notice of proposed sale (Form 144) |
| May 30, 20244 | Insider transaction (Form 4) |
| May 30, 2024144 | Notice of proposed sale (Form 144) |
| May 30, 2024144 | Notice of proposed sale (Form 144) |
| May 30, 2024144 | Notice of proposed sale (Form 144) |
| May 29, 2024144 | Notice of proposed sale (Form 144) |
| May 28, 2024144 | Notice of proposed sale (Form 144) |
The newest 25 of 91 shown; the full year is on EDGAR.
2023 · 86 filings — 54 × 4, 16 × 144, 5 × SC 13G/A and 5 other forms
Counted, not listed; the year is on EDGAR.
2022 · 75 filings — 61 × 4, 5 × SC 13G/A, 2 × 3 and 5 other forms
Counted, not listed; the year is on EDGAR.
2021 · 65 filings — 54 × 4, 5 × SC 13G/A, 2 × 5 and 4 other forms
Counted, not listed; the year is on EDGAR.
2020 · 67 filings — 57 × 4, 7 × SC 13G/A, 2 × 3 and 1 other form
Counted, not listed; the year is on EDGAR.
2019 · 90 filings — 80 × 4, 6 × SC 13G/A, 1 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2018 · 135 filings — 107 × 4, 13 × 4/A, 8 × SC 13G/A and 3 other forms
Counted, not listed; the year is on EDGAR.
2017 · 118 filings — 89 × 4, 5 × 4/A, 5 × SC 13G/A and 11 other forms
Counted, not listed; the year is on EDGAR.
2016 · 114 filings — 92 × 4, 5 × 5, 4 × SC 13G/A and 7 other forms
Counted, not listed; the year is on EDGAR.
2015 · 100 filings — 75 × 4, 7 × SC 13G/A, 4 × SC TO-T/A and 9 other forms
Counted, not listed; the year is on EDGAR.
2014 · 111 filings — 83 × 4, 7 × SC TO-C, 4 × 5 and 11 other forms
Counted, not listed; the year is on EDGAR.
2013 · 131 filings — 105 × 4, 8 × 5, 5 × SC 13G/A and 9 other forms
Counted, not listed; the year is on EDGAR.
2012 · 132 filings — 106 × 4, 6 × SC 13G/A, 3 × 3 and 11 other forms
Counted, not listed; the year is on EDGAR.
2011 · 97 filings — 87 × 4, 6 × SC 13G/A, 1 × 3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2010 · 100 filings — 76 × 4, 4 × 4/A, 4 × CT ORDER and 7 other forms
Counted, not listed; the year is on EDGAR.
2009 · 74 filings — 53 × 4, 7 × SC 13G/A, 3 × 5 and 6 other forms
Counted, not listed; the year is on EDGAR.
2008 · 138 filings — 115 × 4, 8 × SC 13G/A, 5 × CORRESP and 6 other forms
Counted, not listed; the year is on EDGAR.
2007 · 81 filings — 66 × 4, 5 × SC 13G/A, 2 × 4/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2006 · 69 filings — 51 × 4, 5 × SC 13G/A, 4 × 424B5 and 6 other forms
Counted, not listed; the year is on EDGAR.
2005 · 64 filings — 31 × 4, 5 × 3, 5 × SC 13G/A and 12 other forms
Counted, not listed; the year is on EDGAR.
2004 · 47 filings — 26 × 4, 6 × SC 13G, 5 × 424B3 and 5 other forms
Counted, not listed; the year is on EDGAR.
2003 · 36 filings — 19 × 4, 3 × 424B2, 3 × SC 13G/A and 8 other forms
Counted, not listed; the year is on EDGAR.
2002 · 8 filings — 2 × S-3, 2 × S-3/A, 1 × 424B3 and 3 other forms
Counted, not listed; the year is on EDGAR.
2001 · 19 filings — 5 × 424B2, 5 × S-3/A, 3 × S-3 and 5 other forms
Counted, not listed; the year is on EDGAR.
2000 · 3 filings — 2 × SC 13G, 1 × S-3
Counted, not listed; the year is on EDGAR.
1999 · 9 filings — 4 × S-1/A, 1 × 424B4, 1 × 8-A12G and 3 other forms
Counted, not listed; the year is on EDGAR.
About this data
BioMarin Pharmaceutical Inc. (BMRN) has 2,723 filings on EDGAR going back to 1999: 33 annual reports, 85 quarterly reports and 368 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 26, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Sep 30, 2026, covered material definitive agreement. Over the last 13 months insiders sold $4.3M in 5 sales and bought nothing on the open market; 46 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been BioMarin Pharmaceutical Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read BMRN's latest 10-K?
- BMRN's latest annual report, a 10-K, was filed on Feb 26, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did BMRN last file an 8-K?
- On Sep 30, 2026: material definitive agreement. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 6, 2026.
- Are BMRN insiders buying or selling?
- Over the last 13 months insiders sold $4.3M in 5 sales and bought nothing on the open market; 46 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Davis George Eric (EVP, Chief Legal Officer) sold 17,557 shares on Sep 2, 2026 for $1.2M. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has BMRN made?
- 2,723 filings are on EDGAR under the registrant records that have been BioMarin Pharmaceutical Inc., going back to 1999; 1,790 of them are insider ownership forms (Forms 3, 4, 5 and 144).